| Literature DB >> 27977296 |
Edwin J Yoo1,2, Christie A Ojiaku1,2, Krishna Sunder1, Reynold A Panettieri1.
Abstract
Asthma manifests as airway hyperresponsiveness and inflammation, including coughing, wheezing, and shortness of breath. Immune cells and airway structural cells orchestrate asthma pathophysiology, leading to mucus secretion, airway narrowing, and obstruction. Phosphoinositide 3-kinase, a lipid kinase, plays a crucial role in many of the cellular and molecular mechanisms driving asthma pathophysiology and represents an attractive therapeutic target. Here, we summarize the diverse roles of phosphoinositide 3-kinase in the pathogenesis of asthma and discuss novel therapeutic approaches to treatment.Entities:
Keywords: asthma; bronchodilator; inflammation; phosphoinositide 3-kinase
Mesh:
Substances:
Year: 2017 PMID: 27977296 PMCID: PMC5516292 DOI: 10.1165/rcmb.2016-0308TR
Source DB: PubMed Journal: Am J Respir Cell Mol Biol ISSN: 1044-1549 Impact factor: 6.914